Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Assets
Cash and cash equivalents	$ 482,772	$ 1,276,654
Accounts Receivable	4,196
Inventory	6,363
Prepaid expense and other current assets	58,476	26,580
Total current assets	551,807	1,303,234
Patents, net	138,122	146,456
Property and equipment, net	1,753	14,010
Total assets	691,682	1,463,700
Liabilities and Stockholders' Equity
Accounts payable and accrued expenses	179,847	115,313
Advances from investors	56,225	104,952
Convertible notes payable – related party	376,526	513,356
Total current liabilities	612,598	733,621
Total liabilities	612,598	733,621
Stockholders' Equity
Preferred stock, $0.01 par value: Authorized shares - 10,000,000, Issued and outstanding shares – 0 at September 30, 2019 and December 31, 2018
Common stock, $0.01 par value: Authorized shares - 100,000,000, Issued and outstanding shares –40,216,351 and 39,117,524 at September 30, 2019 and December 31, 2018, respectively	402,164	391,175
Additional paid-in capital	4,076,434	3,527,238
Accumulated deficit	(4,399,514)	(3,188,334)
Total stockholders’ equity	79,084	730,079
Total liabilities and stockholders’ equity	$ 691,682	$ 1,463,700